| MUTATIONAL LANDSCAPE OF GINGIVO-BUCCAL ORAL SQUAMOUS CELL CARCINOMA REVEALS NEW RECURRENTLYMUTATED GENES AND MOLECULAR SUBGROUPS IPT the International Cancer Genome Consortium Nature Communications 4 (Article number: 2873 (2013)), 2013 | 200* | 2013 |
| Synthesis and biological evaluation of a novel betulinic acid derivative as an inducer of apoptosis in human colon carcinoma cells (HT-29) B Chakraborty, D Dutta, S Mukherjee, S Das, NC Maiti, P Das, ... European Journal of Medicinal Chemistry 102, 93-105, 2015 | 91 | 2015 |
| pH-sensitive nanodrug carriers for codelivery of ERK inhibitor and gemcitabine enhance the inhibition of tumor growth in pancreatic cancer P Ray, D Dutta, I Haque, G Nair, J Mohammed, M Parmer, N Kale, M Orr, ... Molecular Pharmaceutics 18 (1), 87-100, 2020 | 48 | 2020 |
| Aptamer-conjugated apigenin nanoparticles to target colorectal carcinoma: a promising safe alternative of colorectal cancer chemotherapy D Dutta, A Chakraborty, B Mukherjee, S Gupta ACS Applied Bio Materials 1 (5), 1538-1556, 2018 | 40 | 2018 |
| Nanoencapsulated betulinic acid analogue distinctively improves colorectal carcinoma in vitro and in vivo D Dutta, B Paul, B Mukherjee, L Mondal, S Sen, C Chowdhury, CD Mita Scientific Reports 9 (11506 (2019)), 1-20(https://www.nature.com/articles/s4), 2019 | 36 | 2019 |
| CCN5 activation by free or encapsulated EGCG is required to render triple‐negative breast cancer cell viability and tumor progression A Das, I Haque, P Ray, A Ghosh, D Dutta, M Quadir, A De, ... Pharmacology Research & Perspectives 9 (2), https://doi.org/10.1002/prp2.753, 2021 | 34 | 2021 |
| Metabolic disorder in Alzheimer’s disease MK Poddar, S Banerjee, A Chakraborty, D Dutta Metabolic brain disease 36, 781-813, 2021 | 33 | 2021 |
| Chemical architecture of block copolymers differentially abrogate cardiotoxicity and maintain the anticancer efficacy of doxorubicin CS Abdullah, P Ray, S Alam, N Kale, R Aishwarya, M Morshed, D Dutta, ... Molecular pharmaceutics 17 (12), 4676-4690, 2020 | 33 | 2020 |
| A potent betulinic acid analogue ascertains an antagonistic mechanism between autophagy and proteasomal degradation pathway in HT-29 cells D Dutta, B Chakraborty, A Sarkar, C Chowdhury, P Das BMC cancer 16, 1-19, 2016 | 33 | 2016 |
| CD-340 functionalized doxorubicin-loaded nanoparticle induces apoptosis and reduces tumor volume along with drug-related cardiotoxicity in mice L Mondal, B Mukherjee, K Das, S Bhattacharya, D Dutta, S Chakraborty, ... International Journal of Nanomedicine 14 (XX), 10.2147/IJN.S220740, 2019 | 30 | 2019 |
| Polymeric composite matrix with high biobased content as pharmaceutically relevant molecular encapsulation and release platform RS Hazra, D Dutta, B Mamnoon, G Nair, A Knight, S Mallik, S Ganai, ... ACS Applied Materials & Interfaces 13 (34), 40229-40248, 2021 | 11 | 2021 |
| Phosphorothioated amino-AS1411 aptamer functionalized stealth nanoliposome accelerates bio-therapeutic threshold of apigenin in neoplastic rat liver: a mechanistic approach M Dhara, A Al Hoque, R Sen, D Dutta, B Mukherjee, B Paul, S Laha Journal of Nanobiotechnology 21 (1), 28, 2023 | 7 | 2023 |
| Inhibitory potential of iRGD peptide-conjugated garcinol-loaded biodegradable nanoparticles in rat colorectal carcinoma B Paul, RH Gaonkar, D Dutta, R Dasi, B Mukherjee, S Ganguly, SK Das Biomaterials Advances, 112714, 2022 | 7 | 2022 |
| Functional applications of polyarginine-hyaluronic acid-based electrostatic complexes NR Kale, D Dutta, W Carstens, S Mallik, M Quadir Bioelectricity 2 (2), 158-166, 2020 | 5 | 2020 |
| Induction of apoptosis by a potent Betulinic acid derivative in Human colon carcinoma HT-29 cells D Dutta, A Sarkar, B Chakraborty, C Chowdhury, P Das International Journal of Scientific and Research Publications 5 (2), 1-7, 2015 | 5 | 2015 |
| EVALUATION OF PHYTOCHEMICALS INTERRELATED TO ANTIOXIDANT POTENTIAL OF UNANI PLANTS MD KALIM, D DUTTA, P DAS, S CHATTOPADHYAY International Journal of Pharma and Bio Sciences 6 (3), 330-342, 2015 | 4 | 2015 |
| Recent developments in cancer vaccines: where are we? B Mukherjee, AA Hoque, A Chakraborty, S Chakraborty, L Dutta, D Dutta, ... Nanotherapeutics in Cancer Vaccination and Challenges 3, 60-106, 2022 | 3 | 2022 |
| Nanoformulated drug delivery of potential betulinic acid derivatives: A promising approach toward cancer therapy B Mukherjee, A Al Hoque, D Dutta, B Paul, A Mukherjee, S Mallick Nanomedicine for Bioactives: Healthcare Applications, 127-153, 2020 | 3 | 2020 |
| BCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myeloma D Dutta, J Liu, K Wen, K Kurata, M Fulciniti, A Gulla, T Hideshima, ... Blood Cancer Journal 13 (1), 184, 2023 | 2 | 2023 |
| Recent Trends for Nanomedicine Safety B Mukherjee, D Dutta, P Ghosh, B Paul, R Sen, S Chakraborty Nano Medicine and Nano Safety, 469-509 (10.1007/978-981-15-6255-6_18), 2020 | 2 | 2020 |
BISWAJIT MUKHERJEEProfessor in Pharmaceutics, Department of Pharmaceutical Technology, Jadavpur UniversityVerified email at jadavpuruniversity.in
